Compare FFIN & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFIN | NVST |
|---|---|---|
| Founded | 1890 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 1994 | 2019 |
| Metric | FFIN | NVST |
|---|---|---|
| Price | $31.70 | $24.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $36.50 | $26.46 |
| AVG Volume (30 Days) | 612.9K | ★ 2.8M |
| Earning Date | 04-16-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | 13.46 | ★ 104.31 |
| EPS | ★ 0.50 | 0.23 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $17.16 | $6.67 |
| Revenue Next Year | $6.61 | $3.55 |
| P/E Ratio | ★ $62.78 | $104.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.12 | $16.41 |
| 52 Week High | $38.74 | $30.42 |
| Indicator | FFIN | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 36.73 |
| Support Level | $31.21 | $24.21 |
| Resistance Level | $31.74 | $25.41 |
| Average True Range (ATR) | 0.72 | 1.17 |
| MACD | -0.12 | -0.29 |
| Stochastic Oscillator | 38.16 | 8.47 |
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.